Gynecologic Oncology Field Specialist — MRD Diagnostics

Natera, Inc.; Richmond (VA); On-site; USD 190,000 - 225,000; Full time

Benefits offered by this job

On-target earnings (OTE) $190,000–$225

Monthly car allowance

RSUs & 401(k) with company match

Generous PTO and holidays

Comprehensive health benefits

Job summary

Natera, Inc. in the United States seeks a Clinical Oncology Specialist to drive adoption of Signatera in GYN oncology across the Carolinas and Mid-Atlantic region.

This field-based role requires frequent travel and collaboration with academic centers, hospital systems and community practices. You will engage Gynecologic Oncologists and Medical Oncologists, develop territory strategies, and maintain robust forecasting and relationship management to expand patient access to cutting-edge MRD

Qualifications

• Bachelor's degree required.
• 5+ years of medical sales experience.
• Experience calling on GYN Oncologists or related oncology stakeholders preferred.

Responsibilities

• Develop expertise in Natera’s oncology portfolio and reimbursement landscape.
• Identify and develop relationships with KOLs, academic medical centers, hospital systems and community practices.
• Engage clinicians through consultative discussions to support adoption of Natera’s oncology diagnostics.
• Develop and execute strategic territory plans to identify growth opportunities.
• Achieve sales objectives and drive territory growth.
• Maintain accurate territory activity, customer insights and sales forecasts.

Skills

Medical sales experience

GYN oncology knowledge

Education

Bachelor’s degree

Job description

Natera, Inc. in the United States seeks a Clinical Oncology Specialist to drive adoption of Signatera in GYN oncology across the Carolinas and Mid-Atlantic region.

This field-based role requires frequent travel and collaboration with academic centers, hospital systems and community practices. You will engage Gynecologic Oncologists and Medical Oncologists, develop territory strategies, and maintain robust forecasting and relationship management to expand patient access to cutting-edge MRD